Antibiotic Use Among Hospitalized Children and Neonates in China: Results From Quarterly Point Prevalence Surveys in

Chu-Ning Wang1, Jianning Tong2, Bin Yi3

  • 1Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, China.

Insights

Overuse of broad-spectrum antibiotics in Chinese pediatric hospitals is common, with 70.4% of prescriptions from the WHO Watch group. Routine surveillance using WHO AWaRe metrics is recommended to guide interventions.

Area of Science:

  • Pediatric infectious disease
  • Antimicrobial stewardship
  • Public health surveillance

Background:

  • Antimicrobial resistance poses a significant challenge in pediatric care in China.
  • Antibiotic use surveillance is crucial for evaluating prescribing quality and guiding stewardship interventions.

Purpose of the Study:

  • To assess antibiotic use patterns in pediatric inpatients in China using WHO AWaRe metrics.
  • To identify areas for improvement in antibiotic stewardship.

Main Methods:

  • Quarterly point prevalence surveys conducted in 16 Chinese hospitals in 2019.
  • Data collected from hospital information systems on antibiotic prescriptions for pediatric inpatients.
  • Analysis of prescribing patterns based on WHO AWaRe metrics and Anatomical Therapeutic Chemical (ATC) Classification.

Main Results:

  • 66.1% of 22,327 pediatric inpatients received antibiotics; 59.2% of neonates received antibiotics.
  • High rates of combination antibiotic therapy were observed in PICUs (78.5%) and other wards.
  • WHO Watch group antibiotics comprised 70.4% of prescriptions, with third-generation cephalosporins being most common.

Conclusions:

  • Broad-spectrum Watch group antibiotic overuse is prevalent in Chinese pediatric inpatients.
  • Targeted interventions are needed to reduce Watch antibiotic use within the national stewardship framework.
  • Routine surveillance using WHO AWaRe metrics should be implemented for ongoing monitoring.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
70
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
76
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
96
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
80
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Antibiotic Selection00:57

Antibiotic Selection

Overview
57.0K